Company Introduction
Dr. Reddy’s Laboratories Ltd. is a billion dollar, research led global pharmaceutical company with presence across the pharmaceutical Value Chain. The company manufactures and markets API (Bulk Actives), Finished Dosages and Biologics and has a very promising Drug Discovery Pipeline. The operations are spread over 100 countries including USA, Europe, Russia, India, South East Asia, Africa and the Middle East.
The company has several distinctions to its credit being the first pharmaceutical company from Asia Pacific (outside Japan) to be listed on the New York Stock Exchange, getting a 6 month exclusivity for a block buster generic product in the US, out-licensing products from discovery pipeline to other MNCs and being voted among the best Fortune under billion dollar company.
Hewitt-CNBC has rated Dr. Reddy’s among the best employers in a survey including top companies across various sectors.
For more information refer to company website - www.drreddys.com
Operations in China
China has been identified as one of the most important areas of focus for the company. We have been present in China with a Joint Venture (JV). Also Dr. Reddy’s has started a Representative Office in Shanghai for developing business and building product pipeline for area of operations outside the JV. Larger investments are planned for the future.
The current positions would be for the Dr. Reddy’s Representative Office in Shanghai.
Position – Regulatory (Drug Registration) Affairs Assistant
公司简介
印度瑞迪博士实验室有限公司是印度最大的制药公司之一，销售额过10亿美元、以研发为导向，参与整个医药价值链。我公司生产并销售原料药、成品制剂和生物制剂。药物研发有着很好的前景。公司机构遍布100多个国家和地区，包括美国、欧洲、俄国、印度、东南亚、非洲和中东地区。
几个鲜明的特色使得公司有良好的信誉：瑞迪是亚太地区（除日本）首批在美国纽约证券交易所上市的医药公司；首批在美国市场上获得180日专销权的印度医药公司；印度首批将新化合物实体授权给其他跨国企业的公司；
更多信息请登录公司网站： www.drreddys.com
在中国的机构
中国市场是公司关注的重点。我们在中国设有一家合资企业。公司现在上海也 成立了代表处，希望通过代表处能拓展商务，销售药品。将来这一领域会有更进一步的投资。
现在招聘职位的是瑞迪在上海的代表处。
